We are live on ! Find out more

Medifast

MED

Market cap $141M

12.59 USD

+0.06

0.48%

At close Updated Nov 3, 4:00 PM EST

Pre-market

After hours

12.59

0.00

0%

1 day

0.48%

5 days

0.56%

1 month

7.88%

3 months

29.26%

6 months

18.44%

Year to date

21.06%

1 year

5.98%

5 years

-94.12%

10 years

-68.79%

About: Medifast Inc is a old health and wellness company known for its habit-based and coach-guided lifestyle solution OPTAVIA, which provides people with a simple, yet comprehensive approach to address obesity and support a healthy life. The company provides unparalleled coaching support along with community, tailored nutrition and healthy habits, and empowers people to master their weight loss journey through each stage of life. The company has access to GLP-1 medications where clinically appropriate. The company is focused on offering talent to Lifelong Transformation, Making a Healthy Lifestyle Second Nature.

Employees: 380

Consumer Discretionary Personal Services

News

Positive

Neutral

Negative

Sentiment 3-Months

Positive 37.1%

Neutral 42.9%

Negative 20%

The Motley Fool

Medifast: 3 Key Takeaways for Long-Term Investors

Average revenue per active coach rose 54% year over year. Medifast ended the third quarter with $172.5 million in cash.

Medifast: 3 Key Takeaways for Long-Term Investors

Medifast Is Running The Same Playbook, And I Have The Same Concerns

Medifast (MED) maintains a strong, cash-heavy balance sheet and trades near liquidation value, but its business model remains uninspiring amid GLP-1 disruption. Q3 2026 revenue declined 19.4% YoY to $72M, with active earning coaches down 47%, though average revenue per coach increased. Management transition and Steamboat Capital's activist involvement signal board-level changes, but the core product and MLM-style distribution remain unchanged.

Medifast Is Running The Same Playbook, And I Have The Same Concerns

Zacks Investment Research

Medifast Q3 Loss Narrower Than Expected as Coach Productivity Rises

MED tops Q3 earnings expectations as coach productivity jumps 54.1% and margins expand, despite declining revenues and a shrinking coach network.

Medifast Q3 Loss Narrower Than Expected as Coach Productivity Rises

Medifast, Inc. (MED) Q3 2026 Earnings Call Transcript

Medifast, Inc. (MED) Q3 2026 Earnings Call Transcript

Medifast, Inc. (MED) Q3 2026 Earnings Call Transcript

What Medifast (MED) Said on Its Q3 Earnings Call

Medifast NYSE: MED reported third-quarter 2026 revenue of $72 million, down 19.4% from a year earlier, as the company continued to face a sharp decline in its active earning coach base. Management said revenue was within its guidance range and marked a fourth consecutive quarter in which sales stabilized around the mid-$70 million range.

What Medifast (MED) Said on Its Q3 Earnings Call

Zacks Investment Research

Medifast (MED) Reports Q3 Loss, Tops Revenue Estimates

Medifast (MED) came out with a quarterly loss of $0.19 per share versus the Zacks Consensus Estimate of a loss of $0.4. This compares to a loss of $0.21 per share a year ago.

Medifast (MED) Reports Q3 Loss, Tops Revenue Estimates

Medifast Announces Third Quarter 2026 Financial Results

BALTIMORE--(BUSINESS WIRE)--Medifast (NYSE: MED), the metabolic health and wellness company known for its science-backed comprehensive metabolic health system, Trilivy™, today reported results for the third quarter ended September 30, 2026. Third Quarter 2026 Revenue: $72.0 million, with revenue per active earning coach of $7,064 Independent active earning coaches of 10,200 Net loss of $17.5 million (non-GAAP adjusted net loss of $2.1 million) Loss per diluted share ("EPS") of $1.57 (non-GAAP a.

Medifast Announces Third Quarter 2026 Financial Results

Zacks Investment Research

Medifast Q3 Earnings on the Horizon: Key Insights for Investors

MED's Q3 results are likely to face pressure from GLP-1 adoption, shrinking coach numbers and lower sales, while strategic initiatives may offer some support.

Medifast Q3 Earnings on the Horizon: Key Insights for Investors

Why Is Weight Loss Different During Menopause? Common Myths Debunked

Myth: Menopause weight gain is inevitable. Truth: Acceleration is not inevitable.

Why Is Weight Loss Different During Menopause? Common Myths Debunked

Medifast to Announce Financial Results for the Third Quarter Ended September 30, 2026

BALTIMORE--(BUSINESS WIRE)--Medifast (NYSE: MED), the metabolic health and wellness company known for its science-backed comprehensive metabolic health system, Trilivy™, will announce financial results for the quarter ended September 30, 2026 on Monday, October 26, 2026, before market open. The Company will host a conference call to discuss the results with additional comments and details. Company participants will be Nick Johnson, Chief Executive Officer, and Jim Maloney, Chief Financial Offic.

Medifast to Announce Financial Results for the Third Quarter Ended September 30, 2026

See News Rankings

Price charts implemented using Lightweight Charts™